Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's du ...

Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company developing innovative medicines for ...

Enliven Therapeutics (ELVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sam ...

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

CARDIO4Cities is developed and tested by the Novartis Foundation and it uses data to help policymakers develop better ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Analysts have set 12-month price targets for Incyte, revealing an average target of $73.69, a high estimate of $97.00, and a ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.